Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06063317
Title A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS) (OASIS)
Acronym OASIS
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Imugene Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
Emory Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
Northwestern RECRUITING Chicago Illinois 60208 United States Details
Roswell Park Comprehensive Cancer Center RECRUITING Buffalo New York 14203 United States Details
University of Cincinnati RECRUITING Cincinnati Ohio 45219 United States Details
University of Pittsburgh Medical Center RECRUITING Pittsburgh Pennsylvania 15219 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field